Clinical Trial Update: Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing relative mitochondrial toxicity of tenofovir alafenamide (TAF) vs tenofovir disoproxil fumarate (TDF) in HIV/AIDS, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: University of California, Los Angeles | Conditions: HIV/AIDS, Antiviral Toxicity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-05-10